Search results
1 – 10 of 20The cost will increase pressure on households already experiencing declining real incomes and worrying about the military mobilisation which the government says has taken 300,000…
Details
DOI: 10.1108/OXAN-DB274487
ISSN: 2633-304X
Keywords
Geographic
Topical
Turkmen investment hopes.
Details
DOI: 10.1108/OXAN-DB249915
ISSN: 2633-304X
Keywords
Geographic
Topical
Vaccination, procurement and limited local production are in train but face many systemic obstacles. One state, Turkmenistan, claims it has never had a COVID-19 case, while…
Details
DOI: 10.1108/OXAN-DB259919
ISSN: 2633-304X
Keywords
Geographic
Topical
The vote comes amid an unprecedented economic downturn caused by a combination of factors: low oil prices, recession in Russia and slowdown in China. President Nursultan…
Details
DOI: 10.1108/OXAN-DB210070
ISSN: 2633-304X
Keywords
Geographic
Topical
The extents of reform in Uzbekistan.
Details
DOI: 10.1108/OXAN-DB247998
ISSN: 2633-304X
Keywords
Geographic
Topical
Since coming to power in 2016, Uzbek President Shavqat Mirzioyev has launched wide-ranging structural and economic reforms. There has been progress on economic change, although…
Details
DOI: 10.1108/OXAN-DB239396
ISSN: 2633-304X
Keywords
Geographic
Topical
He has navigated his way through powerful anti-reform lobbies, fears that he was too naive to handle the Kremlin, and concerns about impartiality arising from a July 2019 phone…
Details
DOI: 10.1108/OXAN-DB253148
ISSN: 2633-304X
Keywords
Geographic
Topical
A recent reshuffle raises questions about whether government can avoid returning to old problems of infighting and nepotism; this is important if IMF support is to continue. Until…
Details
DOI: 10.1108/OXAN-DB251831
ISSN: 2633-304X
Keywords
Geographic
Topical
This is still tentative planning but it indicates the Kremlin is being spurred into action by looming curbs on high-carbon products in China and the EU, Russia's key export…
Details
DOI: 10.1108/OXAN-DB263478
ISSN: 2633-304X
Keywords
Geographic
Topical
Russia has a thriving pharmaceutical sector, but companies are struggling to meet the surge in demand for a range of essential drugs. The obstacles come from new supply-chain…